M Demos1, M P McLeod, K Nouri. 1. Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
Abstract
BACKGROUND: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is increasing in incidence and manifests as skin and soft tissue infections including furuncles. The majority of studies have focused on the epidemiology of single furuncles and not recurrent disease. There is a lack of data concerning the incidence of furunculosis outside the U.S.A. OBJECTIVES: This report reviews the literature of recurrent furunculosis and the impact of CA-MRSA on the disease. METHODS: Article citations were searched within PubMed. Search terms used were 'furunculosis', 'recurrent furunculosis', 'skin abscess' and 'recurrent boils'. Articles were discarded if they did not refer to furunculosis secondary to S. aureus. RESULTS: A total of 1515 articles were initially retrieved with the term 'furunculosis', 77 with the term 'recurrent furunculosis', 2778 with the term 'skin abscess', and 1526 with the term 'recurrent boils'. After excluding articles not referring to S. aureus furunculosis, 86 articles were included for this review. CONCLUSIONS: Furunculosis is increasing within the U.S.A. secondary to the CA-MRSA epidemic and the resistant organism's close association with the Panton-Valentine leucocidin (PVL) virulence factor. PVL is associated with follicular infections in general, having its strongest association with furunculosis and its recurrence. The majority of furuncles in the U.S.A. are caused by CA-MRSA, while elsewhere in the world they are caused by methicillin-sensitive S. aureus. Nasal carriage of S. aureus is the primary risk factor for recurrent furunculosis and occurs in 60% of individuals.
BACKGROUND: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is increasing in incidence and manifests as skin and soft tissue infections including furuncles. The majority of studies have focused on the epidemiology of single furuncles and not recurrent disease. There is a lack of data concerning the incidence of furunculosis outside the U.S.A. OBJECTIVES: This report reviews the literature of recurrent furunculosis and the impact of CA-MRSA on the disease. METHODS: Article citations were searched within PubMed. Search terms used were 'furunculosis', 'recurrent furunculosis', 'skin abscess' and 'recurrent boils'. Articles were discarded if they did not refer to furunculosis secondary to S. aureus. RESULTS: A total of 1515 articles were initially retrieved with the term 'furunculosis', 77 with the term 'recurrent furunculosis', 2778 with the term 'skin abscess', and 1526 with the term 'recurrent boils'. After excluding articles not referring to S. aureus furunculosis, 86 articles were included for this review. CONCLUSIONS:Furunculosis is increasing within the U.S.A. secondary to the CA-MRSA epidemic and the resistant organism's close association with the Panton-Valentine leucocidin (PVL) virulence factor. PVL is associated with follicular infections in general, having its strongest association with furunculosis and its recurrence. The majority of furuncles in the U.S.A. are caused by CA-MRSA, while elsewhere in the world they are caused by methicillin-sensitive S. aureus. Nasal carriage of S. aureus is the primary risk factor for recurrent furunculosis and occurs in 60% of individuals.
Authors: Shirish Balachandra; Maria Pardos de la Gandara; Scott Salvato; Tracie Urban; Claude Parola; Chamanara Khalida; Rhonda G Kost; Teresa H Evering; Mina Pastagia; Brianna M D'Orazio; Alexander Tomasz; Herminia de Lencastre; Jonathan N Tobin Journal: Microb Drug Resist Date: 2015-02-10 Impact factor: 3.431
Authors: David A Talan; Frank Lovecchio; Fredrick M Abrahamian; David J Karras; Mark T Steele; Richard E Rothman; Anusha Krishnadasan; William R Mower; Rebecca Hoagland; Gregory J Moran Journal: Clin Infect Dis Date: 2016-03-29 Impact factor: 9.079
Authors: Virginia Abatángelo; Natalia Peressutti Bacci; Carina A Boncompain; Ariel F Amadio; Soledad Carrasco; Cristian A Suárez; Héctor R Morbidoni Journal: PLoS One Date: 2017-07-25 Impact factor: 3.240
Authors: Fabiana Venegas Pires; Maria de Lourdes Ribeiro de Souza da Cunha; Lígia Maria Abraão; Patrícia Y F Martins; Carlos Henrique Camargo; Carlos Magno Castelo Branco Fortaleza Journal: PLoS One Date: 2014-03-24 Impact factor: 3.240
Authors: Amy Flaxman; Elizabeth Allen; Claudia Lindemann; Yuko Yamaguchi; Matthew K O'Shea; Joanne L Fallowfield; Michael Lindsay; Frances Gunner; Kyle Knox; David H Wyllie Journal: BMJ Open Date: 2016-06-02 Impact factor: 2.692
Authors: Larissa S May; Mark Zocchi; Catherine Zatorski; Jeanne A Jordan; Richard E Rothman; Chelsea E Ware; Samantha Eells; Loren Miller Journal: West J Emerg Med Date: 2015-10-20